Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
5 Most Expected Film Delivery - 2Select Your Definitive Pizza Decision
- 3IDF says up to 90% of Iran’s weapons industry could be hit within days
- 4Two UN peacekeepers killed in explosion in Lebanon
- 5China's 'Venice Of The East' Is A Historic Canal City Near Shanghai With Arched Bridges And Lantern-Lit Waterways
- Coca-Cola Co. and bottlers to invest in South Africa operations
- Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan
- Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video)
- Over 250,000 cases of shredded cheese recalled over possible metal fragments
- Turning into a Distributed Writer: My Composing Process
- Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
- People who talk with their hands seem more clear and persuasive – new research
- New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
- The Craft of Computerized Detox: Individual Trials
